R Marcos-Gragera1,2,3, J Galceran4,5,6, C Martos7,8,9, A L de Munain10, M Vicente-Raneda11, C Navarro12,13,9, J R Quirós-Garcia14, M-J Sánchez15,9, E Ardanaz16,17,9, M Ramos18, A Mateos19, D Salmerón12,13,9, S Felipe20, R Peris-Bonet20. 1. Epidemiology Unit and Girona Cancer Registry (UERCG), Oncology Coordination Plan (PDO), Department of Health, Autonomous Government of Catalonia, Girona, Spain. rmarcos@iconcologia.net. 2. Descriptive Epidemiology, Genetics and Cancer Prevention Group [Girona Biomedical Research Institute] IDIBGI, Catalan Institute of Oncology-Girona (ICO), Girona, Spain. rmarcos@iconcologia.net. 3. Nursing Department, University of Girona (UdG), Girona, Spain. rmarcos@iconcologia.net. 4. Tarragona Cancer Registry, Foundation Society for Cancer Research and Prevention (FUNCA), Reus, Spain. 5. Pere Virgili Health Research Institute, Reus, Spain. 6. Rovira i Virgili University (URV), Reus, Spain. 7. Zaragoza Cancer Registry, Aragon Government, Saragossa, Spain. 8. Centre of Public Health Research-FISABIO, Valencia, Spain. 9. Consortium for Biomedical Research in Epidemiology and Public Health (CIBER en Epidemiología y Salud Pública CIBERESP), Madrid, Spain. 10. Basque Country Cancer Registry, Basque Government, Vitoria-Gasteiz, Spain. 11. Community Valenciana Childhood Cancer Registry, Public Health Directorate, Conselleria de Sanitat Universal i Salut Pública, Generalitat Valenciana, Valencia, Spain. 12. Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain. 13. Department of Health and Social Sciences, Universidad de Murcia, Murcia, Spain. 14. Public Health Directorate, Asturias, Spain. 15. Granada Cancer Registry, Andalusian School of Public Health, Granada, Spain. 16. Navarre Cancer Registry, Navarre Public Health Institute, Pamplona, Spain. 17. IdiSNA, Navarra Institute for Health Research, Pamplona, Spain. 18. Mallorca Cancer Registry, Epidemiology Department, Directorate-General of Public Health and Participation, Palma de Mallorca, Spain. 19. Albacete Cancer Registry, Health and Social Welfare Authority, Albacete, Spain. 20. Spanish Childhood Cancer Registry (RETI-SEHOP), Spanish Society of Paediatric Haematology and Oncology, University of Valencia, Valencia, Spain.
Abstract
OBJECTIVE: We have analysed incidence and survival trends of children and adolescents with leukaemia registered in Spanish population-based cancer registries during the period 1983-2007. METHODS: Childhood and adolescent leukaemia cases were drawn from the 11 Spanish population-based cancer registries. For survival, registries with data for the period 1991-2005 and follow-up until 31-12-2010 were included. Overall incidence trends were evaluated using joinpoint analysis. Observed survival rates were estimated using Kaplan-Meier, and trends were tested using the log-rank test. RESULTS: Based on 2606 cases (2274 children and 332 adolescents), the overall age-adjusted incidence rate (ASRw) of leukaemia was 47.9 cases per million child-years in children and 23.8 in adolescents. The ASRw of leukaemia increased with an annual percentage change of 9.6 % (95 % CI: 2.2-17.6) until 1990 followed by a stabilisation of rates. In adolescents, incidence did not increase. Five-year survival increased from 66 % in 1991-1995 to 76 % in 2001-2005. By age, survival was dramatically lower in infants (0) and adolescents (15-19) than in the other age groups and no improvement was observed. In both children and adolescents, differences in 5-year survival rates among major subgroups of leukaemias were significant. CONCLUSIONS: The increasing incidence trends observed in childhood leukaemias during the study period were confined to the beginning of the period. Remarkable improvements in survival have been observed in Spanish children with leukaemias. However, this improvement was not observed in infants and adolescents.
OBJECTIVE: We have analysed incidence and survival trends of children and adolescents with leukaemia registered in Spanish population-based cancer registries during the period 1983-2007. METHODS: Childhood and adolescent leukaemia cases were drawn from the 11 Spanish population-based cancer registries. For survival, registries with data for the period 1991-2005 and follow-up until 31-12-2010 were included. Overall incidence trends were evaluated using joinpoint analysis. Observed survival rates were estimated using Kaplan-Meier, and trends were tested using the log-rank test. RESULTS: Based on 2606 cases (2274 children and 332 adolescents), the overall age-adjusted incidence rate (ASRw) of leukaemia was 47.9 cases per million child-years in children and 23.8 in adolescents. The ASRw of leukaemia increased with an annual percentage change of 9.6 % (95 % CI: 2.2-17.6) until 1990 followed by a stabilisation of rates. In adolescents, incidence did not increase. Five-year survival increased from 66 % in 1991-1995 to 76 % in 2001-2005. By age, survival was dramatically lower in infants (0) and adolescents (15-19) than in the other age groups and no improvement was observed. In both children and adolescents, differences in 5-year survival rates among major subgroups of leukaemias were significant. CONCLUSIONS: The increasing incidence trends observed in childhood leukaemias during the study period were confined to the beginning of the period. Remarkable improvements in survival have been observed in Spanish children with leukaemias. However, this improvement was not observed in infants and adolescents.
Entities:
Keywords:
Adolescent leukaemia; Cancer registry; Cancer survival; Childhood cancer; Childhood leukaemia; Global health
Authors: Gemma Gatta; Giulia Zigon; Riccardo Capocaccia; Jan Willem Coebergh; Emmanuel Desandes; Peter Kaatsch; Guido Pastore; Rafael Peris-Bonet; Charles A Stiller Journal: Eur J Cancer Date: 2009-02-21 Impact factor: 9.162
Authors: F Bautista; A Cañete; G L Ramírez-Villar; J M Fernández; J L Fuster; C Diaz de Heredia; I Astigarraga; M García-Ariza; S Rives; J L Dapena; C Márquez; A Molinés; M Del M Bermúdez; S Gallego; M Del M Andrés; J Verdu-Amoros; C Hernández; M López; A Catalá; Á Lassaletta; O Cruz; M Ramírez; F Lendínez; A Carboné; J Gomez Sirvent; M Tallón; T Acha; L Moreno; A Fernández-Teijeiro Journal: Clin Transl Oncol Date: 2019-10-09 Impact factor: 3.405
Authors: J Ribes; L Pareja; X Sanz; S Mosteiro; J M Escribà; L Esteban; J Gálvez; G Osca; P Rodenas; P Pérez-Sust; J M Borràs Journal: ESMO Open Date: 2022-04-14
Authors: Eva Steliarova-Foucher; Miranda M Fidler; Murielle Colombet; Brigitte Lacour; Peter Kaatsch; Marion Piñeros; Isabelle Soerjomataram; Freddie Bray; Jan Willem Coebergh; Rafael Peris-Bonet; Charles A Stiller Journal: Lancet Oncol Date: 2018-08-08 Impact factor: 41.316
Authors: J Smith Torres-Roman; Bryan Valcarcel; Pedro Guerra-Canchari; Camila Alves Dos Santos; Isabelle Ribeiro Barbosa; Carlo La Vecchia; Katherine A McGlynn; Dyego Leandro Bezerra de Souza Journal: BMC Pediatr Date: 2020-11-07 Impact factor: 2.125